Saudi Diagnostic Limited (SDL) has announced the launch of its Comprehensive Laboratory Test Directory, featuring more than 2,900 medical tests across diverse specialties. The directory provides detailed information for each test, including required sample type, turnaround time (TAT), scientific description, and preparation notes, making it a unified and accessible reference for physicians, specialists, hospitals, and laboratories.

Key Statistics and Specialties

• General & Diagnostic Tests (1,677): Routine blood tests, liver and kidney function tests, and standard panels.
• Immunology & Allergy (288): Antibody tests, allergy panels, and autoimmune diagnostics.
• Pathology & Histology (261): Tissue and cellular examinations, and tumor pathology diagnostics.
• Genetics & Genomics (206): Chromosomal studies, rare disease genetic testing, and predisposition panels.
• Hematology (158): Complete blood counts, coagulation tests, and inherited blood disorder diagnostics.
• Microbiology & Infectious Diseases (142): Bacterial and viral cultures, fungal testing, and infection diagnostics.
• Oncology & Tumor Markers (72): Tumor markers such as PSA, CA-125, and AFP.
• Endocrinology & Hormones (72): Thyroid function, fertility hormones, and growth hormones.
• Biochemistry & Metabolism (48): Lipid profiles, vitamin analysis, and metabolic disorder indicators.
• Clinical Chemistry (42): Glucose, cholesterol, and cardiac enzymes.
• Prenatal & Reproductive Tests (5): Fertility tests and genetic screening before pregnancy.

Vision and Objectives

This initiative is part of SDL’s commitment to Saudi Vision 2030, which aims to enhance quality of life and position the Kingdom as a regional hub for healthcare and precision medicine. The directory’s primary objective is to support physicians, specialists, hospitals, and laboratories by facilitating access to advanced test information, enabling faster diagnostics, improving patient outcomes, and optimizing healthcare efficiency.

With this launch, SDL strengthens its role as a leader in innovative diagnostic solutions, aligned with the Kingdom’s healthcare transformation goals and its ambition to lead the region in advanced medical sciences.